XML 81 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Stockholders’ Equity (USD $)
Preferred Stock [Member]
Common Stock [Member]
USD ($)
Additional Paid-in Capital [Member]
USD ($)
Retained Earnings [Member]
USD ($)
Total
USD ($)
Beginning balance at Dec. 31, 2012   $ 8,300 $ 62,425,400 $ (68,865,900)  
Beginning balance (in Shares) at Dec. 31, 2012 0 82,616,750      
Employee stock option issuances (in Shares)   751,378      
Exercise of warrants (in Shares)   9,917,500      
Vesting of restricted stock awards (in Shares)   776,889      
Net loss       (597,800) (597,800)
Stock-based compensation expense     427,200    
Issuance of new warrants, per exercise agreement     514,800    
New warrants recorded as cost of exercise agreement     (514,800)    
Reclassification of warrants liability to equity from exercise of warrants     348,300    
Reclassification of warrants liability to equity from amendment of warrants     4,391,000    
Exercise of employee stock options   100 112,400    
Exercise of warrants   800 2,550,200    
Vesting of restricted stock awards   200      
Total Stockholders’ Equity at Jun. 30, 2013   9,400 70,254,500 (69,463,700) 800,200
Ending balance (in Shares) at Jun. 30, 2013 0 94,062,517      
Beginning balance at Dec. 31, 2013   9,800 71,697,300 (72,611,900) (904,800)
Beginning balance (in Shares) at Dec. 31, 2013 0 98,510,622      
Private placement of stock and warrants (in Shares)   11,299,999      
Employee stock option issuances (in Shares)   256,818      
Exercise of warrants (in Shares)   1,000,000      
Vesting of restricted stock awards (in Shares)   818,394      
Net loss       (1,652,700) (1,652,700)
Stock-based compensation expense     330,200    
Private placement of common stock and warrants   1,200 3,388,800    
Cost of private placement of common stock and warrants     (20,000)    
Allocation of proceeds from common stock and warrants to warrants liability     (1,356,000)    
Accretion of compensation expense, net of forfeitures – consultant warrants     (3,600)    
Exercise of employee stock options     47,800    
Exercise of warrants   100 259,800    
Vesting of restricted stock awards   100      
Total Stockholders’ Equity at Jun. 30, 2014   $ 11,200 $ 74,344,300 $ (74,264,600) $ 90,900
Ending balance (in Shares) at Jun. 30, 2014 0 111,885,833